BioDefense Therapeutics (BD Tx)
Fort Belvoir
Virginia
United States
Tel: 410-436-9000
Fax: N?/A
Website: http://www.jpeocbd.osd.mil/
Email: cbrn.irc@us.army.mil
About BioDefense Therapeutics (BD Tx)
BioDefense Therapeutics is a Joint Product Management office within the Medical Countermeasure Systems (JPM-MCS) Joint Project Management Office. A component of the Joint Program Executive Office for Chemical and Biological Defense, JPM-MCS aims to provide U.S. military forces and the nation with safe, effective and innovative medical solutions to counter chemical, biological, radiological and nuclear threats. JPM-MCS facilitates the advanced development and acquisition of medical countermeasures and systems to enhance our nation's biodefense response capability.3 articles about BioDefense Therapeutics (BD Tx)
-
Sarepta Therapeutics Announces Publication Of Ebola And Marburg Phase 1 Clinical Study Results; Contract With BioDefense Therapeutics
10/17/2014
-
DoD's BioDefense Therapeutics Announces First Patient Enrolled In Phase 3 Clinical Trials For Favipiravir (Contract With MediVector)
1/7/2014
-
DoD's BioDefense Therapeutics Announces Positive Phase 2 Results For Flu Drug Favipiravir (Contract With MediVector)
10/16/2013